nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Breast disorder—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Vigabatrin—Malaise—Prednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Vigabatrin—Vertigo—Prednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Vigabatrin—Eye disorder—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Vigabatrin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Vigabatrin—Back pain—Triamcinolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Vigabatrin—Convulsion—Prednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Vigabatrin—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Vigabatrin—Discomfort—Prednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Vigabatrin—Angioedema—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Vigabatrin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Vigabatrin—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Vigabatrin—Hallucination—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Vigabatrin—Malaise—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Vigabatrin—Malaise—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Vigabatrin—Vertigo—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Vigabatrin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Vigabatrin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Vigabatrin—Oedema—Prednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Vigabatrin—Cough—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Vigabatrin—Convulsion—Triamcinolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Vigabatrin—Convulsion—Methylprednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Vigabatrin—Myalgia—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Myalgia—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Eye disorder—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Anxiety—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Depression—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Discomfort—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Vigabatrin—Discomfort—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Vigabatrin—Angioedema—Betamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Vigabatrin—Angioedema—Dexamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Vigabatrin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Vigabatrin—Malaise—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Malaise—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Oedema—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Vertigo—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Vertigo—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Vigabatrin—Infection—Triamcinolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Vigabatrin—Infection—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Vigabatrin—Insomnia—Prednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Vigabatrin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Vigabatrin—Mental disorder—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Vigabatrin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Vigabatrin—Malnutrition—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Vigabatrin—Convulsion—Betamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Vigabatrin—Convulsion—Dexamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Vigabatrin—Myalgia—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Vigabatrin—Myalgia—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Vigabatrin—Anxiety—Dexamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Vigabatrin—Anxiety—Betamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Vigabatrin—Discomfort—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Vigabatrin—Discomfort—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Vigabatrin—Pain—Prednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Vigabatrin—Vision blurred—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Oedema—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Oedema—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Vigabatrin—Insomnia—Triamcinolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Insomnia—Methylprednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Infection—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Infection—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Vigabatrin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Anaemia—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Vigabatrin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Vigabatrin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Vigabatrin—Agitation—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Vigabatrin—Angioedema—Prednisone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Vigabatrin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Vigabatrin—Malaise—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Vertigo—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Vigabatrin—Urticaria—Prednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Vigabatrin—Fatigue—Triamcinolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Vigabatrin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Vigabatrin—Pain—Triamcinolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Vigabatrin—Convulsion—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Myalgia—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Arthralgia—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Vigabatrin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Vigabatrin—Anxiety—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Vigabatrin—Insomnia—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Vigabatrin—Insomnia—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Vigabatrin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Vigabatrin—Paraesthesia—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Vigabatrin—Discomfort—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Vigabatrin—Urticaria—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Vigabatrin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Oedema—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Decreased appetite—Betamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Vigabatrin—Infection—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Fatigue—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Fatigue—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Vigabatrin—Pain—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Vigabatrin—Pain—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Vigabatrin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Vigabatrin—Skin disorder—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Vigabatrin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Vigabatrin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Vigabatrin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Vigabatrin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Vigabatrin—Urticaria—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Urticaria—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Dizziness—Prednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Asthenia—Triamcinolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Vigabatrin—Insomnia—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Vigabatrin—Pruritus—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Vigabatrin—Cough—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Vigabatrin—Pruritus—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Vigabatrin—Dyspepsia—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Decreased appetite—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Rash—Prednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Dermatitis—Prednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Vigabatrin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Vigabatrin—Fatigue—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Vigabatrin—Headache—Prednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Vigabatrin—Constipation—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Vigabatrin—Dizziness—Triamcinolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Vigabatrin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Vigabatrin—Infection—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Vigabatrin—Asthenia—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Vigabatrin—Asthenia—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Vigabatrin—Nausea—Prednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Vigabatrin—Pruritus—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Vigabatrin—Pruritus—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Vigabatrin—Vomiting—Triamcinolone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Vigabatrin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000989	0.000989	CcSEcCtD
Vigabatrin—Rash—Triamcinolone—psoriatic arthritis	0.000983	0.000983	CcSEcCtD
Vigabatrin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000982	0.000982	CcSEcCtD
Vigabatrin—Rash—Methylprednisolone—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Vigabatrin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00098	0.00098	CcSEcCtD
Vigabatrin—Urticaria—Prednisone—psoriatic arthritis	0.000979	0.000979	CcSEcCtD
Vigabatrin—Headache—Triamcinolone—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Vigabatrin—Headache—Methylprednisolone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Vigabatrin—Abdominal pain—Prednisone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Vigabatrin—Body temperature increased—Prednisone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Vigabatrin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000968	0.000968	CcSEcCtD
Vigabatrin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000968	0.000968	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000938	0.000938	CcSEcCtD
Vigabatrin—Dizziness—Dexamethasone—psoriatic arthritis	0.000936	0.000936	CcSEcCtD
Vigabatrin—Dizziness—Betamethasone—psoriatic arthritis	0.000936	0.000936	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—psoriatic arthritis	0.000931	0.000931	CcSEcCtD
Vigabatrin—Nausea—Triamcinolone—psoriatic arthritis	0.000926	0.000926	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—psoriatic arthritis	0.000925	0.000925	CcSEcCtD
Vigabatrin—Nausea—Methylprednisolone—psoriatic arthritis	0.000924	0.000924	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—psoriatic arthritis	0.000916	0.000916	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000908	0.000908	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Vigabatrin—Vomiting—Dexamethasone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Vigabatrin—Vomiting—Betamethasone—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000895	0.000895	CcSEcCtD
Vigabatrin—Rash—Betamethasone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Vigabatrin—Rash—Dexamethasone—psoriatic arthritis	0.000892	0.000892	CcSEcCtD
Vigabatrin—Dermatitis—Betamethasone—psoriatic arthritis	0.000891	0.000891	CcSEcCtD
Vigabatrin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000891	0.000891	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000889	0.000889	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—psoriatic arthritis	0.000888	0.000888	CcSEcCtD
Vigabatrin—Headache—Betamethasone—psoriatic arthritis	0.000886	0.000886	CcSEcCtD
Vigabatrin—Headache—Dexamethasone—psoriatic arthritis	0.000886	0.000886	CcSEcCtD
Vigabatrin—Asthenia—Prednisone—psoriatic arthritis	0.000884	0.000884	CcSEcCtD
Vigabatrin—Pain—Methotrexate—psoriatic arthritis	0.000881	0.000881	CcSEcCtD
Vigabatrin—Pruritus—Prednisone—psoriatic arthritis	0.000872	0.000872	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000849	0.000849	CcSEcCtD
Vigabatrin—Diarrhoea—Prednisone—psoriatic arthritis	0.000843	0.000843	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000842	0.000842	CcSEcCtD
Vigabatrin—Nausea—Dexamethasone—psoriatic arthritis	0.00084	0.00084	CcSEcCtD
Vigabatrin—Nausea—Betamethasone—psoriatic arthritis	0.00084	0.00084	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—psoriatic arthritis	0.000818	0.000818	CcSEcCtD
Vigabatrin—Dizziness—Prednisone—psoriatic arthritis	0.000815	0.000815	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Vigabatrin—Vomiting—Prednisone—psoriatic arthritis	0.000784	0.000784	CcSEcCtD
Vigabatrin—Rash—Prednisone—psoriatic arthritis	0.000777	0.000777	CcSEcCtD
Vigabatrin—Dermatitis—Prednisone—psoriatic arthritis	0.000776	0.000776	CcSEcCtD
Vigabatrin—Headache—Prednisone—psoriatic arthritis	0.000772	0.000772	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000759	0.000759	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—psoriatic arthritis	0.000739	0.000739	CcSEcCtD
Vigabatrin—Nausea—Prednisone—psoriatic arthritis	0.000732	0.000732	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—psoriatic arthritis	0.000729	0.000729	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000705	0.000705	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—psoriatic arthritis	0.000681	0.000681	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—psoriatic arthritis	0.000655	0.000655	CcSEcCtD
Vigabatrin—Rash—Methotrexate—psoriatic arthritis	0.000649	0.000649	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—psoriatic arthritis	0.000649	0.000649	CcSEcCtD
Vigabatrin—Headache—Methotrexate—psoriatic arthritis	0.000645	0.000645	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—psoriatic arthritis	0.000612	0.000612	CcSEcCtD
